<DOC>
	<DOCNO>NCT00432432</DOCNO>
	<brief_summary>Combination Methotrexate Infliximab : Influence immunogenicity efficacy infliximab patient Ankylosing Spondylitis .</brief_summary>
	<brief_title>Combination Methotrexate Infliximab</brief_title>
	<detailed_description>Forty consecutive patient recruit rheumatology clinic Prince Wales Hospital AS meeting modify New York criterion active disease define ( see ) . They randomize receive MTX 7.5 mg/week initially weekly 2.5mg increment 15mg/week dosage reach , ( i.e week 6 ) placebo together folic acid 5mg daily period 16 week . After 16 week , patient receive infliximab 5 mg/kg per dose , week 16 , 18 , 22 ( 3 dos ) , continue MTX 15 mg/week placebo . Thereafter , follow week 30 , 38 week . MRI change sacroiliac joint ( SI ) infliximab treatment .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Fulfilled AS : meeting modify New York criterion Active disease despite NSAID treatment define : Spinal inflammation ≧ 30 score 30 least two three domain Back pain Patient global assessment disease activity Physical function Informed consent Complete ankylosis spine On sulphasalazine Previous use TNF inhibitor Multiple use NSAIDS Prednisolone &gt; 10mg/day Changes NSAIDS dose prednisolone within 2 week baseline Little ability selfcare Received intraarticular , intramuscular , intravenous corticosteroid 4 week screen Infected joint prosthesis previous 5 year Serious infection , hepatitis , pneumonia , pyelonephritis previous 3 month Any chronic infectious disease renal infection , chest infection bronchiectasis sinusitis Active tuberculosis require treatment within previous 3 year Opportunistic infection herpes zoster within previous 2 month Any evidence active cytomegalovirus ; active Pneumocystis carinii ; drugresistant atypical mycobacterial infection Known hypersensitivity murine proteins Current sign symptom severe , progressive , uncontrolled renal , hepatic , haematological , gastrointestinal , endocrine , pulmonary , cardiac , neurological , cerebral disease A history lymphoproliferative disease include lymphoma sign suggestive disease , lymphadenopathy unusual size location ( ie , lymph node posterior triangle neck , infraclavicular epitrochlear , periaortic area ) ; splenomegaly ; Any know malignant disease except basal cell carcinoma currently past 5 year . A hemoglobin level &lt; 8.5 gm/dl , white blood cell count &lt; 3.5 × 10^9/liter , platelet count &lt; 100 × 10^9/liter , serum creatinine level &gt; 150 µmol/l , serum transaminase level 1.25 time upper limit normal , alkaline phosphatase level &gt; 2 time upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Ankylosing Spondylitis</keyword>
	<keyword>MTX</keyword>
	<keyword>Infliximab</keyword>
</DOC>